NewsBenzinga미들비, 4분기 조정 주당순이익 1.76~1.92달러 전망, 예상치 1.79달러 상회; 매출 6억 2,100만~6억 3,500만 달러 전망, 예상치 6억 3,095만 6천 달러 하회 미들비, 4분기 조정 주당순이익 1.76~1.92달러 전망, 예상치 1.79달러 상회; 매출 6억 2,100만~6억 3,500만 달러 전망, 예상치 6억 3,095만 6천 달러 하회 Benzinga 2026.11.05 12:15 (GMT+0) Open on Benzinga Other news Global-E Online Stock Is Falling Wednesday: What's Going On? Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6 Stifel Maintains Buy on Ecolab, Raises Price Target to $356 Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $26 Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients
Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease
Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients